Literature DB >> 12135483

Differential regulation of telomerase activity by six telomerase subunits.

Joseph Tung-Chieh Chang1, Yin-Ling Chen, Huei-Ting Yang, Chi-Yuan Chen, Ann-Joy Cheng.   

Abstract

Telomerase is a specialized reverse transcriptase responsible for synthesizing telomeric DNA at the ends of chromosomes. Six subunits composing the telomerase complex have been cloned: hTR (human telomerase RNA), TEP1 (telomerase-associated protein 1), hTERT (human telomerase reverse transcriptase), hsp90 (heat shock protein 90), p23, and dyskerin. In this study, we investigated the role of each the telomerase subunit on the activity of telomerase. Through down- or upregulation of telomerase, we found that only hTERT expression changed proportionally with the level of telomerase activity. The other components, TEP1, hTR, hsp90, p23, and dyskerin remained at high and unchanged levels throughout modulation. In vivo and in vitro experiments with antisense oligonucleotides against each telomerase component were also performed. Telomerase activity was decreased or abolished by antisense treatment. To correlate clinical sample status, four pairs of normal and malignant tissues from patients with oral cancer were examined. Except for the hTERT subunit, which showed differential expression in normal and cancer tissues, all other components were expressed in both normal and malignant tissues. We conclude that hTERT is a regulatable subunit, whereas the other components are expressed more constantly in cells. Although hTERT has a rate-limiting effect on enzyme activity, the other telomerase subunits (hTR, TEP1, hsp90, p23, dyskerin) participated in full enzyme activity. We hypothesize that once hTERT is expressed, all other telomerase subunits can be assembled to form a highly active holoenzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135483     DOI: 10.1046/j.1432-1033.2002.03025.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  21 in total

1.  In silico evaluation of TERT inhibition by anticancer drugs.

Authors:  Porika Mahendar; Kalam Sirisha; Umasankar Kulandaivelu; Prakhya Laxmi Jaya Shankar; Tippani Radhika; Abbagani Sadanandam
Journal:  J Mol Model       Date:  2012-06-06       Impact factor: 1.810

2.  Correlation of dyskerin expression with active proliferation independent of telomerase.

Authors:  Faizan Alawi; Ping Lin; Barry Ziober; Reena Patel
Journal:  Head Neck       Date:  2010-12-08       Impact factor: 3.147

3.  Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells.

Authors:  Jun Liu; Yazhou Yao; Huifang Ding; Renan Chen
Journal:  Tumour Biol       Date:  2014-02-23

4.  Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.

Authors:  Fang Li; Jinquan Cui
Journal:  Med Oncol       Date:  2015-06-12       Impact factor: 3.064

Review 5.  Glioma: what is the role of c-Myc, hsp90 and telomerase?

Authors:  A Shervington; N Cruickshanks; H Wright; R Atkinson-Dell; R Lea; G Roberts; L Shervington
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

6.  Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.

Authors:  Atsuo Nakamura; Takeshi Suda; Terasu Honma; Toru Takahashi; Masato Igarashi; Nobuo Waguri; Hirokazu Kawai; Yusaku Mita; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase.

Authors:  Qing-You Du; Xiao-Bo Wang; Xue-Jun Chen; Wei Zheng; Sheng-Qi Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.

Authors:  Carsten Boltze; Hendrik Lehnert; Regine Schneider-Stock; Brigitte Peters; Cuong Hoang-Vu; Albert Roessner
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

9.  Increased telomerase activity and hTERT expression in human salivary gland carcinomas.

Authors:  Hideo Shigeishi; Masaru Sugiyama; Hidetoshi Tahara; Shigehiro Ono; Ujjal Kumar Bhawal; Masaya Okura; Mikihiko Kogo; Masanori Shinohara; Masanobu Shindoh; Satoru Shintani; Hiroyuki Hamakawa; Takashi Takata; Nobuyuki Kamata
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

10.  DKC1 overexpression associated with prostate cancer progression.

Authors:  P Sieron; C Hader; J Hatina; R Engers; A Wlazlinski; M Müller; W A Schulz
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.